CD274 and melanoma: However, based on the reported data including ours1,4,41, some melanoma patients with high level of sEV PD-L1 also showed good therapeutic response whereas some patients with low level of sEV PD-L1 did not respond to the therapy, suggesting that the pre-treatment level of sEV PD-L1 alone is imperfect to predict the patient response.